- Aryna Sabalenka makes history as the first woman in over a decade to successfully defend her US Open title.
- An AI-powered advertisement featuring Aryna Sabalenka achieved viral status, accumulating 233 million Instagram views and appearing on Times Square billboards during the US Open.
- In just nine months since its launch, IM8 has garnered over 300,000 customer purchases and distributed more than 6 million servings.
CHARLOTTE, N.C., Sept. 08, 2025 — Prenetics Global Limited (NASDAQ: PRE), a prominent health sciences company, along with its premium supplement brand IM8, co-founded by David Beckham, today proudly congratulated World No. 1 tennis player Aryna Sabalenka. Sabalenka, a global ambassador and shareholder, successfully defended her singles championship at the 2025 US Open.
This landmark victory signifies a remarkable period for both Prenetics and IM8, as their primary athlete ambassador secured her second consecutive win at one of tennis’s most esteemed tournaments. Sabalenka’s triumph makes her the first woman to defend the US Open title since Serena Williams in 2014, bringing her Grand Slam tally to four. Having started using IM8 Daily Ultimate Essentials earlier this year and becoming the company’s inaugural active athlete shareholder, Sabalenka exemplifies the IM8 brand’s essence through her outstanding resilience, resolve, and peak athletic displays.
Since launching in December 2024, IM8 has seen rapid expansion, recording over 300,000 customer purchases and more than 6 million servings delivered, a testament to strong consumer trust and product approval. The brand’s increasing visibility was further boosted by a recent AI-driven advertisement starring Aryna Sabalenka, which achieved viral success on Instagram with over 233 million views since August 25th. This campaign was also prominently featured on large Times Square billboards throughout the US Open and is set to continue through September.
“I am absolutely delighted to have successfully defended my US Open title,” Aryna Sabalenka stated. “This win is a culmination of tremendous effort from my entire team. A significant factor in my achievement is my dedication to health and recovery, and IM8 Daily Ultimate Essentials has become a crucial element of my daily regimen.”
Danny Yeung, CEO and Co-Founder of Prenetics and IM8, shared his enthusiasm: “We are immensely proud of Aryna’s remarkable triumph at the US Open and her successful title defense. The fact that the World No. 1 is both our global ambassador and our first active athlete shareholder lends even greater significance to this accomplishment. Her achievements underscore the very foundation of what we’ve developed at IM8, and it is our privilege to back her pursuit of excellence.”
Sabalenka, recently appointed a Prenetics shareholder and global ambassador for IM8, has concluded a dominant season by securing her second consecutive US Open singles title. Her involvement with IM8 originated from a recommendation by her performance coach, Jason Stacy. Following more than three months of noticeable benefits, Aryna Sabalenka’s team initiated contact, leading to a multi-year partnership with IM8.
IM8 Daily Ultimate Essentials offers a complete, all-in-one supplement solution, designed to supersede 16 individual supplements. It delivers 92 vital nutrients, including vitamins, minerals, probiotics, and clinical concentrations of CoQ10 and MSM, all in a palatable drink. Particularly important for professional athletes, IM8 holds NSF Certified for Sport accreditation, guaranteeing the absence of prohibited substances and adherence to the stringent quality and safety benchmarks demanded by top-tier competitors.
About Prenetics Global Limited
Prenetics (NASDAQ:PRE), a prominent health sciences company, is committed to enhancing consumer health. Its consumer efforts are spearheaded by IM8, a rapidly expanding health and wellness brand; Europa, a major sports distribution company in the USA; and CircleDNA, a leading direct-to-consumer DNA testing service. Pioneering the convergence of healthcare innovation and digital asset integration, Prenetics is the first healthcare company to establish a Bitcoin treasury, commencing with an initial $20 million Bitcoin acquisition and a board-approved comprehensive Bitcoin strategy. For further details, please visit prenetics.com and IM8health.com
About IM8
IM8 represents the ultimate in premium core nutrition, originating from a partnership with co-founding partner David Beckham and an esteemed group of scientists from medical, academic, and space science fields. By integrating advanced scientific research with nature’s most powerful components, IM8 offers a holistic, scientifically validated method for health, enabling individuals to experience their most energetic lives. IM8’s primary offering, Daily Ultimate Essentials, is an all-in-one powdered supplement designed to substitute 16 different supplements in a palatable drink. It is NSF Certified for Sport, non-GMO, vegan, free from common allergens, and contains no artificial flavors, colors, or sweeteners. IM8 operates as a wholly-owned subsidiary of Prenetics (NASDAQ: PRE), a leading global health sciences company focused on advancing consumer health.
Media Contact:
Angela Cheung
Investor Relations / Corporate Finance
Prenetics Global Limited
Danielle Mulholland
Jack Taylor Public Relations
